Defining the Mycobiome in Bladder Cancer.
作者信息
Mercier Benjamin D, Castro Daniela V, Pal Sumanta K
机构信息
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
出版信息
Eur Urol Open Sci. 2022 Dec 27;48:70-71. doi: 10.1016/j.euros.2022.11.023. eCollection 2023 Feb.
Abstract
摘要
相似文献
1
Defining the Mycobiome in Bladder Cancer.定义膀胱癌中的真菌微生物组。
Eur Urol Open Sci. 2022 Dec 27;48:70-71. doi: 10.1016/j.euros.2022.11.023. eCollection 2023 Feb.
2
The mycobiome of the human urinary tract: potential roles for fungi in urology.人类泌尿道的真菌群落：真菌在泌尿学中的潜在作用。
Ann Transl Med. 2017 Jan;5(2):31. doi: 10.21037/atm.2016.12.69.
3
The oral mycobiome: Oral epithelial dysplasia and oral squamous cell carcinoma.口腔真菌组：口腔上皮异型增生和口腔鳞状细胞癌。
J Oral Pathol Med. 2022 May;51(5):413-420. doi: 10.1111/jop.13295. Epub 2022 Apr 11.
4
Mycobiome and Cancer: What Is the Evidence?真菌微生物组与癌症：有哪些证据？
Cancers (Basel). 2021 Jun 24;13(13):3149. doi: 10.3390/cancers13133149.
5
Smokeless tobacco consumption induces dysbiosis of oral mycobiome: a pilot study.无烟烟草消费可引起口腔菌失调：一项初步研究。
Appl Microbiol Biotechnol. 2022 Sep;106(17):5643-5657. doi: 10.1007/s00253-022-12096-6. Epub 2022 Aug 1.
6
The Salivary Mycobiome Contains 2 Ecologically Distinct Mycotypes.唾液微生物组包含 2 种生态上不同的真菌型。
J Dent Res. 2020 Jun;99(6):730-738. doi: 10.1177/0022034520915879. Epub 2020 Apr 21.
7
[Human mycobiome and diseases].[人类真菌微生物组与疾病]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2019 Jun 1;37(3):314-319. doi: 10.7518/hxkq.2019.03.017.
8
Profiling the Human Oral Mycobiome in Tissue and Saliva Using ITS2 DNA Metabarcoding Compared to a Fungal-Specific Database.与真菌特异性数据库相比，使用ITS2 DNA宏条形码分析组织和唾液中的人类口腔真菌群落。
Methods Mol Biol. 2021;2327:253-269. doi: 10.1007/978-1-0716-1518-8_15.
9
The lung mycobiome in the next-generation sequencing era.下一代测序时代的肺部真菌菌群
Virulence. 2017 Apr 3;8(3):334-341. doi: 10.1080/21505594.2016.1235671. Epub 2016 Sep 29.
10
The gut mycobiome: a novel player in chronic liver diseases.肠道共生真菌：慢性肝病的新角色。
J Gastroenterol. 2021 Jan;56(1):1-11. doi: 10.1007/s00535-020-01740-5. Epub 2020 Nov 5.
本文引用的文献
1
Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer.人类肠道真菌群落与真菌群落相互作用：膀胱癌化疗反应状态中未知的“火枪手”
Eur Urol Open Sci. 2022 Jul 12;43:5-13. doi: 10.1016/j.euros.2022.06.005. eCollection 2022 Sep.
2
Biomarker approach harnessed in trials of personalized medicine for bladder cancer.生物标志物方法在膀胱癌个性化医疗试验中得到应用。
Nat Med. 2021 May;27(5):761-763. doi: 10.1038/s41591-021-01300-1.
3
The microbiome and human cancer.微生物组与人类癌症。
Science. 2021 Mar 26;371(6536). doi: 10.1126/science.abc4552.
4
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.粪便微生物移植克服了黑色素瘤患者对抗 PD-1 治疗的耐药性。
Science. 2021 Feb 5;371(6529):595-602. doi: 10.1126/science.abf3363.
5
The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL.真菌微生物组通过激活 MBL 促进胰腺发生癌变。
Nature. 2019 Oct;574(7777):264-267. doi: 10.1038/s41586-019-1608-2. Epub 2019 Oct 2.
6
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.结直肠癌中的肠真菌微生物失调和生态改变。
Gut. 2019 Apr;68(4):654-662. doi: 10.1136/gutjnl-2018-317178. Epub 2018 Nov 24.
7
Strains, functions and dynamics in the expanded Human Microbiome Project.扩展的人类微生物组计划中的菌株、功能与动态
Nature. 2017 Oct 5;550(7674):61-66. doi: 10.1038/nature23889. Epub 2017 Sep 20.
8
The mechanism of action of BCG therapy for bladder cancer--a current perspective.BCG 疗法治疗膀胱癌的作用机制——当前的观点。
Nat Rev Urol. 2014 Mar;11(3):153-62. doi: 10.1038/nrurol.2014.15. Epub 2014 Feb 4.
9
Cytotoxic xanthone-anthraquinone heterodimers from an unidentified fungus of the order Hypocreales (MSX 17022).来自 Hypocreales 目（MSX 17022）未知真菌的细胞毒黄烷酮-蒽醌杂二聚体。
J Antibiot (Tokyo). 2012 Jan;65(1):3-8. doi: 10.1038/ja.2011.95. Epub 2011 Nov 9.
10
Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group.干酪乳杆菌制剂在双盲试验中对浅表性膀胱癌复发的预防作用。BLP研究组
Eur Urol. 1995;27(2):104-9. doi: 10.1159/000475138.
Zotero 插件